Huntington National Bank’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 4370 |
|
|
2025
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 4337 |
|
|
2025
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 4300 |
|
|
2025
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 4330 |
|
|
2025
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 4364 |
|
|
2024
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 4338 |
|
|
2024
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 4322 |
|
|
2024
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 4253 |
|
|
2024
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 4118 |
|
|
2023
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 4066 |
|
|
2023
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 4009 |
|
|
2023
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 3924 |
|
|
2023
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 3753 |
|
|
2022
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 3684 |
|
|
2022
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 3112 |
|
|
2022
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 3114 |
|
|
2022
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 3038 |
|
|
2021
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 2965 |
|
|
2021
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 2688 |
|
|
2021
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 2577 |
|
|
2021
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 2469 |
|
|
2020
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 2445 |
|
|
2020
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 2388 |
|
|
2020
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 2404 |
|
|
2020
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 2499 |
|
|
2019
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 2507 |
|
|
2019
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 2415 |
|
|
2019
Q2 | $0 | Buy |
+1
| New | – | ﹤0.01% | 2449 |
|
|
2019
Q1 | – | Sell |
-1
| Closed | – | – | 2442 |
|
|
2018
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 2495 |
|
|
2018
Q3 | $0 | Buy |
+1
| New | – | ﹤0.01% | 2480 |
|
|
2016
Q2 | – | Sell |
-369
| Closed | -$29K | – | 1918 |
|
|
2016
Q1 | $29K | Buy |
+369
| New | +$4.79K | ﹤0.01% | 1268 |
|
|
2015
Q3 | – | Sell |
-336
| Closed | -$17K | – | 1897 |
|
|
2015
Q2 | $17K | Sell |
336
-33
| -9% | -$1.97K | ﹤0.01% | 1406 |
|
|
2015
Q1 | $29K | Hold |
369
| – | – | ﹤0.01% | 1271 |
|
|
2014
Q4 | $22K | Buy |
+369
| New | +$18.5K | ﹤0.01% | 1338 |
|
Huntington National Bank's OREX Position: Q1 2026 in Review
Huntington National Bank held its Orexigen Therapeutics, Inc. (OREX) position steady in Q1 2026 at 1 share worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #4370.
Huntington National Bank first reported a position in OREX in Q4 2014 and has held it in 34 quarters since. The position peaked at $29K in Q1 2016. 1 fund tracked by Wall St. Rank holds OREX as of Q1 2026.
- Huntington National Bank held 1 share of Orexigen Therapeutics, Inc. worth $0 as of Q1 2026.
- Huntington National Bank left its Orexigen Therapeutics, Inc. share count unchanged in Q1 2026.
- Orexigen Therapeutics, Inc. made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #4370 holding.
- Huntington National Bank first reported a position in Orexigen Therapeutics, Inc. in Q4 2014 and has held it in 34 quarters since.
- Huntington National Bank's Orexigen Therapeutics, Inc. position peaked at $29K in Q1 2016.
- 1 fund tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q1 2026.
Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.